Dapagliflozin Propanediol Monohydrate API

Holiness Pharmaceutical Ltd is a trusted and leading supplier, exporter and manufacturer of Dapagliflozin Propanediol Monohydrate API, delivering high-quality anti-diabetic APIs to pharmaceutical companies across 40+ international markets. Dapagliflozin Propanediol Monohydrate is a widely used SGLT2 inhibitor for the treatment of Type 2 Diabetes Mellitus and cardiovascular risk management, making us a reliable Dapagliflozin bulk API supplier from India.

Globally, Holiness Pharmaceutical is recognized among reputable Dapagliflozin API manufacturers, offering high assay purity, controlled related substances, stable crystalline form, and consistent particle size distribution suitable for oral solid dosage formulations. Our expertise in SGLT2 inhibitor molecules positions us as a dependable Pharmaceutical API exporter.

Our advanced API manufacturing facilities operate in strict compliance with international pharmaceutical regulatory standards including:
➡ DCGI, WHO-GMP, US-FDA aligned, and cGMP guidelines,
ensuring validated synthesis processes, robust impurity profiling, moisture control, and full pharmacopeial compliance for Dapagliflozin Propanediol Monohydrate API.

We export Dapagliflozin Propanediol Monohydrate API from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions, supporting manufacturers producing diabetes and cardiometabolic care formulations. Holiness Pharmaceutical is widely trusted as a bulk Dapagliflozin API supplier.

Holiness Pharmaceutical is one of the leading producers of Active Pharmaceutical Ingredients (APIs) and Intermediates, delivering GMP-compliant manufacturing systems, consistent batch quality, and globally accepted regulatory documentation as a certified Pharmaceutical API exporter.

Holiness Pharmaceutical Ltd manages the complete lifecycle of API development — including R&D innovation, process optimization, commercial-scale manufacturing, quality assurance, and global distribution.

Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.